Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. (Q45974680)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Acinetobacter baumannii

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Giuseppe Signoriello

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Matteo Bassetti

7

object named as

Matteo Bassetti

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Claudio Viscoli

13

object named as

Claudio Viscoli

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

author name string

Emanuele Durante-Mangoni

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Roberto Andini

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Annunziata Mattei

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Maria De Cristoforo

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Patrizia Murino

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Paolo Malacarne

8

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Nicola Petrosillo

9

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Nicola Galdieri

10

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Paola Mocavero

11

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Antonio Corcione

12

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Raffaele Zarrilli

14

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Ciro Gallo

15

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Riccardo Utili

16

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

language of work or name

0 references

publication date

24 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

57

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

349-358

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Acinetobacter infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Acinetobacter baumannii: emergence of a successful pathogen

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Current control and treatment of multidrug-resistant Acinetobacter baumannii infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Global spread of carbapenem-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Treatment of Acinetobacter infections.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Multidrug-resistant bacteria: overcoming antibiotic permeability barriers of gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Colistin dosing and nephrotoxicity in a large community teaching hospital

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Colistin pharmacokinetics: the fog is lifting

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Nephrotoxicity of intravenous colistin: a prospective evaluation

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Attributable mortality of Acinetobacter baumannii: no longer a controversial issue

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Identifiers

10.1093/CID/CIT253

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45974680&oldid=1886739035"